Survival analysis and risk factors for mortality in connective tissue disease-associated pneumomediastinum

详细信息    查看全文

• 作者：Lu Zhang (1)
  Min Shen (2)
  Fengchun Zhang (2)
  Fulin Tang (2)
  
• 关键词：Connective tissue disease ; Mortality ; Pneumomediastinum ; Survival analysis
• 刊名：Rheumatology International
• 出版年：2014
• 出版时间：December 2014
• 年：2014
• 卷：34
• 期：12
• 页码：1657-1663
• 全文大小：201 KB
• 参考文献：1. Bradley JD (1986) Spontaneous pneumomediastinum in adult dermatomyositis. Ann Rheum Dis 45(9):780-82 CrossRef
  2. Le Goff B, Cherin P, Cantagrel A, Gayraud M, Hachulla E, Laborde F, Papo T, Sibilia J, Zabraniecki L, Ravaud P, Puéchal X (2009) Pneumomediastinum in interstitial lung disease associated with dermatomyositis and polymyositis. Arthritis Rheum 61(1):108-18 CrossRef
  3. Paira SO, Roverano S (1992) Bilateral pneumothorax and mediastinal emphysema in systemic lupus erythematosus. Clin Rheumatol 11(4):571-73 CrossRef
  4. Mohammad A, Low TB, O’Dwyer D, McElvaney G, Kearns G (2007) Spontaneous Pneumo-mediastinum in systemic sclerosis—a case report. Rheumatology 46(8):1376-377 CrossRef
  5. Patel A, Kesler B, Wise RA (2000) Persistent pneumomediastinum in interstitial fibrosis associated with rheumatoid arthritis treatment with high-concentration oxygen. Chest 117(6):1809-813 CrossRef
  6. Kono H, Inokuma S, Nakayama H, Suzuki M (2000) Pneumomediastinum in dermatomyositis: association with cutaneous vasculopathy. Ann Rheum Dis 59(5):372-76 CrossRef
  7. Ye Q, Zhang L, Tian X, Shi J (2011) Exacerbation of pneumomediastinum after air travel in a patient with dermatomyositis. Aviat Space Environ Med 82(7):734-36 CrossRef
  8. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292(8):403-07 CrossRef
  9. Sontheimer RD (2002) Would a new name hasten the acceptance of amyopathic dermatomyositis (dermatomyositis sine myositis) as a distinctive subset within the idiopathic inflammatory dermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 46(4):626-36 CrossRef
  10. Hochberg MC (1997) Updating the American College of rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40(9):1725 CrossRef
  11. Lightfoot RW, Michel BA, Bloch DA, Hunder GG, Zvaifler NJ, McShane DJ, Arend WP, Calabrese LH, Leavitt RY, Lie JT et al (1990) The American College of rheumatology 1990 criteria for the classification of polyarteritis nodosa. Arthritis Rheum 33(8):1088-093 CrossRef
  12. Mosca M, Neri R, Bombardieri S (1998) Undifferentiated connective tissue diseases (UCTD): a review of the literature and a proposal for preliminary classification criteria. Clin Exp Rheumatol 17(5):615-20
  13. Paramasivam E, Bodenham A (2008) Air leaks, pneumothorax, and chest drains. Continuing education in anaesthesia. Crit Care Pain 8(6):204-09
  14. Tang R, Millett CR, Green JJ (2013) Amyopathic dermatomyositis complicated by pneumomediastinum. J Clin Aesthet Dermatol 6(3):40-3
  15. Mancino L, Michieletto L, Trani B, Zamperlin A, Ceron L (2010) Pneumomediastinum after transbronchial lung biopsy. J Bronchol Interv Pulmonol 17(2):167-68 CrossRef
  16. Yagi T, Yamagishi F, Sasaki Y, Mizutani F, Wada A, Kuroda F (2002) Clinical review of pneumothorax cases complicated with active pulmonary tuberculosis. Kekkaku:[Tuberculosis] 77(5):395-99. (Article in Japanese)
  17. de Souza NevesF, Shinjo SK, Carvalho JF, Levy-Neto M, Borges CTL (2007) Spontaneous pneumomediastinum and dermatomyositis may be a not so rare association: report of a case and review of the literature. Clin Rheumatol 26(1):105-07 CrossRef
  18. Ghazi E, Sontheimer RD, Werth VP (2013) The importance of including amyopathic dermatomyositis in the idiopathic inflammatory myositis spectrum. Cl
• 作者单位：Lu Zhang (1)
  Min Shen (2)
  Fengchun Zhang (2)
  Fulin Tang (2)
  
  1. Department of Internal Medicine, Peking Union Medical College Hospital (PUMCH), Chinese Academy of Medical Sciences (CAMS) and Peking Union Medical College (PUMC), Beijing, 100032, China
  2. Department of Rheumatology, PUMCH, CAMS and PUMC, Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, 100032, China
  
• ISSN：1437-160X

文摘

The aim of this study was to analyze the characteristics of patients with diffuse connective tissue diseases (CTDs) complicated by pneumomediastinum and identify the risk factors associated with increased mortality in these patients. Twenty-eight patients with CTD-associated pneumomediastinum, who were admitted to our hospital from January 1997 to June 2012, were prospectively studied. Their demographic characteristics, time to death, and potential risk factors were assessed. Survival curves were depicted by the Kaplan–Meier method. Univariate and multivariate survival analyses were performed by Cox regression. Of the 28 patients, 21 had dermatomyositis; two, polymyositis; three, systemic lupus erythematosus; one, polyarteritis nodosa; and one, undifferentiated CTD. The mean follow-up period was 1,461?days (54-,264). The cumulative estimated Kaplan–Meier survival rate was 68?% at 1?week, 50?% at 1?month, and 43?% at 1?year. According to univariate analysis, higher serum albumin level (HR 0.87, 95?% CI 0.78-.98), “slow air leak-(defined as time to progression of dyspnea [newly acquired respiratory failure, mechanical ventilation required, or decrease in PaO2?>30?mmHg after pneumomediastinum])?>3?days (HR 0.07, 95?% CI 0.02-.34), and early initiation of immunosuppressive agents (within 1?month of steroid therapy; HR 0.27, 95?% CI 0.09-.81) were associated with better prognosis. Final regression analysis revealed that slow air leak was associated with a lower mortality risk. We found that slow air leak was independently associated with better prognosis. Furthermore, most patients (86?%) who survived for at least 1?month following the pneumomediastinum event subsequently survived beyond 1?year.